A Comprehensive Analysis of Conventional Acupuncture and Pharmacological Approaches for Cardiac Arrhythmias: An

Tamam Mohamad1, Mahima Khatri2, Satesh Kumar3

  • 1Department of Cardiology, Wayne State University/Detroit Medical Center, Detroit, MI, USA.

Insights

Acupuncture shows promise for managing cardiac arrhythmias, significantly reducing ventricular premature beats and improving atrial fibrillation/flutter recurrence rates compared to standard treatments. Further research is needed to define its role in treating supraventricular tachycardia and heart rate.

Area of Science:

  • Integrative and Complementary Medicine
  • Cardiology
  • Clinical Research

Background:

  • Cardiac arrhythmias (CAs) pose a significant global health challenge, with increasing prevalence, particularly in older populations.
  • Existing pharmacological treatments for CAs have limitations and potential side effects, necessitating exploration of alternative therapeutic strategies.
  • Acupuncture, a traditional Chinese medicine technique, is increasingly being investigated for its potential role in managing cardiovascular conditions.

Purpose of the Study:

  • To conduct an umbrella review comparing the safety and effectiveness of acupuncture versus pharmacological treatments for cardiac arrhythmias.
  • To address critical gaps in understanding the optimal therapeutic approaches for managing various types of CAs.
  • To evaluate the quality and certainty of evidence from existing systematic reviews and randomized controlled trials (RCTs).

Main Methods:

  • Systematic literature search of PubMed, EMBASE, and Cochrane Database of Systematic Reviews for data up to September 2023.
  • Inclusion of peer-reviewed systematic reviews and meta-analyses based on RCTs.
  • Assessment of evidence certainty using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method and review quality using AMSTAR 2 and Cochrane Collaboration tools.

Main Results:

  • Acupuncture demonstrated a statistically significant reduction in the recurrence of ventricular premature beats (VPBs) compared to pharmacological treatment.
  • While acupuncture showed a trend towards reduced recurrence for paroxysmal atrial fibrillation (AF)/atrial flutter and paroxysmal supraventricular tachycardia (SVT), these differences were not statistically significant.
  • Acupuncture exhibited a favorable safety profile with effectively managed adverse events; however, its effect on heart rate reduction was not statistically significant and showed high heterogeneity.

Conclusions:

  • Acupuncture appears effective in reducing the recurrence of VPBs and shows potential benefits for AF/atrial flutter, though not statistically significant.
  • The current evidence does not support a significant benefit of acupuncture over pharmacological treatments for paroxysmal SVT or post-treatment heart rate.
  • While acupuncture presents a promising safety profile and potential efficacy for specific arrhythmias, further rigorous research is essential to establish its definitive role in CA management.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
912
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
211
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
738
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
490
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421